KAMADA ORD ILS1.00 (KMDA): Can This Small Pharma Company’s Investors Breathe Easy?
Investors have reasons to be wary about small-cap biotech companies, particularly those ambitious start-ups which have been sprouting like mushrooms in the market this year.
